Aurinia Pharmaceuticals Inc. (AUPH) Financial Statements (2026 and earlier)

Company Profile

Business Address #140, 14315 - 118 AVENUE
EDMONTON, AB T5L 4S6
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments397,944358,439350,369389,306465,821398,329
Cash and cash equivalent80,16083,39648,75594,088231,643272,350
Short-term investments317,784275,043301,614295,218234,178125,979
Receivables      1,018
Inventory, net of allowances, customer advances and progress billings45,69039,22839,70524,75219,32613,927
Inventory45,69039,22839,70524,75219,32613,927
Prepaid expense4,0045,5749,48613,58012,5066,153
Other current assets1,0801,1291,0311,334796 
Other undisclosed current assets43,24942,22624,20913,56714,875 
Total current assets:491,967446,596424,800442,539513,324419,427
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization73,86592,072108,715   
Operating lease, right-of-use asset3,5964,0684,4984,9075,3835,489
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,1112,7313,3543,6504,4184,786
Long-term investments and receivables   201  24,380
Long-term investments   201  24,380
Intangible asset, including goodwill, after accumulated amortization3,7614,3554,9776,4258,4049,332
Intangible asset, excluding goodwill, after accumulated amortization3,7614,3554,9776,4258,4049,332
Deferred income tax assets176,194     
Other noncurrent assets938231,51713,33911,838247
Total noncurrent assets:259,620104,049123,26228,32130,04344,234
TOTAL ASSETS:751,587550,645548,062470,860543,367463,661
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:66,62170,15854,38939,99034,94724,797
Employee-related liabilities✕✕✕✕✕18,24211,307
Accounts payable3,3135,1874,3273,0873,8792,635
Accrued liabilities66,62164,97128,34322,9338,44310,855
Other undisclosed accounts payable and accrued liabilities(3,313) 21,71913,9704,383 
Deferred revenue3,72011,0024,8133,148  
Debt16,52314,04614,609   
Other liabilities2,4801,5312,3882,0334,6406,118
Other undisclosed current liabilities4,3801,0269899361,0591,082
Total current liabilities:93,72497,76377,18846,10740,64631,997
Noncurrent Liabilities
Long-term debt and lease obligation52,32258,55475,479 7,6807,619
Finance lease, liability52,32258,55475,479   
Liabilities, other than long-term debt17,54816,85017,44119,31815,9501,589
Deferred revenue12,648     
Other liabilities 11,10710,91112,16615,9501,589
Operating lease, liability4,9005,7436,5307,1527,6807,619
Other undisclosed noncurrent liabilities6,662    14,706
Total noncurrent liabilities:76,53275,40492,92019,31823,63023,914
Total liabilities:170,256173,167170,10865,42564,27655,911
Equity
Equity, attributable to parent, including:581,331377,478377,954405,435479,091407,750
Additional paid in capital111,263126,999120,78885,48959,01439,383
Accumulated other comprehensive loss(599)(647)(730)(1,061)(852)(805)
Accumulated deficit(649,368)(936,570)(942,322)(864,302)(756,122)(575,156)
Other undisclosed equity, attributable to parent1,120,0351,187,6961,200,2181,185,3091,177,051944,328
Total equity:581,331377,478377,954405,435479,091407,750
TOTAL LIABILITIES AND EQUITY:751,587550,645548,062470,860543,367463,661

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues283,055235,133175,513134,03045,60550,118
Cost of revenue(32,665)(28,248)(14,148)(5,664)(1,091) 
Cost of product and service sold   (916)(3,646)  
Gross profit:250,390206,885161,365128,36644,51450,118
Operating expenses  (49,641)(44,988)(53,237)(154,408)
Other operating income (expense), net(9,530)4,347(8,379)1,523(574) 
Other undisclosed operating loss(135,946)(215,919)(195,036)(196,371)(171,438) 
Operating income (loss):104,914(4,687)(91,691)(111,470)(180,735)(104,290)
Nonoperating income
(Investment Income, Nonoperating)		13,57316,970    
Interest and debt expense(4,330)(4,835)(2,775)   
Income (loss) from continuing operations before equity method investments, income taxes:114,1577,448(94,466)(111,470)(180,735)(104,290)
Other undisclosed income from continuing operations before income taxes   16,9975,1185291,516
Income (loss) from continuing operations before income taxes:114,1577,448(77,469)(106,352)(180,206)(102,774)
Income tax expense (benefit)173,045(1,696)(551)(1,828)(760)94
Income (loss) from continuing operations:287,2025,752(78,020)(108,180)(180,966)(102,680)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(180,966)(102,680)
Net income (loss) available to common stockholders, diluted:287,2025,752(78,020)(108,180)(180,966)(102,680)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):287,2025,752(78,020)(108,180)(180,966)(102,680)
Other comprehensive loss    (209)(47) 
Comprehensive income (loss):287,2025,752(78,020)(108,389)(181,013)(102,680)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent4883331   
Comprehensive income (loss), net of tax, attributable to parent:287,2505,835(77,689)(108,389)(181,013)(102,680)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: